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We have utilized patients' own oral mucosa as a cell source for the fabrication of transplantable epithelial
cell sheets to treat limbal stem cell deﬁciency and mucosal defects after endoscopic submucosal
dissection of esophageal cancer. Because there are abundant microbiotas in the human oral cavity, the
oral mucosa was sterilized and 40 mg/mL gentamicin and 0.27 mg/mL amphotericin B were added to the
culture medium in our protocol. Although an oral surgeon carefully checked each patient's oral cavity
and although candidiasis was not observed before taking the biopsy, contamination with Candida albi-
cans (C. albicans) was detected in the conditioned medium during cell sheet fabrication. After adding
1 mg/mL amphotericin B to the transportation medium during transport from Nagasaki University
Hospital to Tokyo Women's Medical University, which are 1200 km apart, no proliferation of C. albicans
was observed. These results indicated that the supplementation of transportation medium with anti-
mycotics would be useful for preventing contamination with C. albicans derived from the oral mucosa
without hampering cell proliferation.
© 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. All
rights reserved., Dulbecco's modiﬁed Eagle's medium.
1; fax: þ81 3 3359 6046.
. Yamato).
Society for Regenerative Medicine.
equally to this work.
ative Medicine. Production and hosting by Elsevier B.V. All rights reserved.
R. Takagi et al. / Regenerative Therapy 1 (2015) 1e42Cultured oral mucosal epithelial cells have been utilized for
sympatric and ectopic transplantation to reconstruct stratiﬁed
epithelia such as the oral mucosa, skin, and cornea [1e3]. After
optimizing culture medium containing autologous serum for
fabricating autologous oral mucosal epithelial cell sheets, we have
treated an esophageal ulcer resulting from endoscopic mucosal
dissection of a mucosal tumor by performing endoscopic trans-
plantation of autologous oral mucosal epithelial cell sheets fabri-
cated on temperature-responsive cell culture surfaces to promote
wound healing and prevent stenosis [4e6].
Because the human oral cavity contains abundant microbiota,
biopsies of oral mucosa are treated with povidone-iodine.
Furthermore, biopsies are stored in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 86 mg/mL ampicillin-
sulbactam (Unasyn-S; Pﬁzer, NY, USA) and 100 mg/mL strepto-
mycin (Meiji Seika Pharma, Tokyo, Japan) during transport from
the oral surgery department to the cell culture facility. Moreover,
the tissue is treated with povidone-iodine in the cell culture fa-
cility and is treated with dispase in DMEM including the same
concentrations of ampicillin-sulbactam and streptomycin for
epithelium separation. In addition, we add 40 mg/mL gentamicin
(Gentacin; Schering-Plough, NJ, USA) and 0.27 mg/mL amphoter-
icin B (Fungizone; Bristol-Myers Squibb, NY, USA) to the culture
medium to maintain a sterile environment. Therefore, we have
not experienced bacterial or fungal contamination in 8 biopsies
from healthy volunteer donors in a preclinical study or in 10 bi-
opsies from patients suffering from esophageal cancer treated at
Tokyo Women's Medical University [6,7]. We have performed
another clinical research study to examine the safety of long-
distance transport of fabricated cell sheets between Tokyo
Women's Medical University and Nagasaki University Hospital,
which are approximately 1200 km apart, with transport taking
5e7 h by air and train. The protocol for oral mucosal epithelial cell
sheet transplantation into patients was approved by the Ethical
Committees and Internal Review Boards of Nagasaki University
and Tokyo Women's Medical University. Approval of this clinical
study by the Health, Labour and Welfare Ministry was gained on
March 29th, 2013. Unfortunately, we experienced contamination
with a yeast-like fungus in the culture supernatant of a patient's
oral mucosal epithelial cells, so we abandoned the fabricated cell
sheets for transplantation. We then performed sterilization testsTable 1
The results of quality control tests.
Sample Items
Cell culture supernatant (1st trial)a Sterilization test
Mycoplasmal culture
Mycoplasma test (PCR)b
Endotoxin
Reagents for cultivation Sterilization test
Serum (patient) Sterilization test
Oral surface (patient) Sterilization test
Oral surface (operator 1) Sterilization test
Oral surface (operator 2) Sterilization test
Cell culture supernatant (2nd trial)a Sterilization test
Oral surface (patient) Sterilization test
a Cell culture supernatants were routinely used for quality control tests.
b PCR for detecting Mycoplasma pneumoniae was performed in accordance with methto identify the source of the contamination and the strain of the
fungus. Supernatants from each sample were cultured in
soybean-casein digest broth (Wako Pure Chemical Industries,
Osaka, Japan) and alternative thioglycollate medium (Wako Pure
Chemical Industries). The strain of the cultured fungus was
identiﬁed using CHROMagar Candida (Becton, Dickinson and
Company, NJ, USA) and API 20C AUX (bioMerieux, Lyon, France).
The obtained results revealed that the patient's oral mucosa was
the source of C. albicans (C. albicans), as described below (Table 1).
The oral mucosal tissue appeared macroscopically healthy
(Fig. 1A), and there was no Candida antigen or infection with
C. albicans in the patient's serum, which was added to the culture
medium (Table 1). In addition, the cultured oral mucosal epithe-
lial cells exhibited normal cell morphology (Fig. 1B,C). However,
contaminating C. albicans and hyphal formation were detected
during epithelial cell culture (Fig. 1D,E). It should be noted that
hyphal formation by C. albicans was inhibited under anaerobic
conditions [8].
We then tested the susceptibility of the C. albicans strain ob-
tained from the conditioned medium and the oral surface of the
patient to antimycotic agents using a commercially prepared
colorimetric microdilution panel (ASTY; Kyokuto Pharmaceutical
Industrial, Tokyo, Japan) [9]. The proliferation of the strain was
completely inhibited by 0.5 mg/mL amphotericin B. In compari-
son, in previous susceptibility testing, the proliferation of nearly
all Candida species was inhibited by 1.0 mg/mL amphotericin B
[10], and a higher concentration of amphotericin B often hampers
mammalian cell proliferation [11]. Therefore, we changed our
protocol for the transport of oral mucosal biopsies from Nagasaki
University Hospital to Tokyo Women's Medical University. The
DMEM used for the transportation was supplemented with
1.0 mg/mL amphotericin B, and the concentration of amphotericin
B in the culture medium was kept at 0.27 mg/mL, with no
modiﬁcation.
It took approximately 6 h to transport the biopsy by air and train,
and then the transported biopsy was subjected to harvesting of the
oral mucosal epithelial cells using dispase treatment for 2 h at 37 C
in DMEM supplemented with the same concentration of ampho-
tericin B. As a result, no contamination with C. albicans was
observed in the supernatant of the culture medium used for the
fabrication of transplantable epithelial cell sheets from the sameResult
Bacteria Negative
Fungi Candida albicans
Negative
Negative
0.062 EU/mL
Bacteria Negative
Fungi Negative
Bacteria Negative
Fungi Negative
Candida antigen Negative
Fungi Candida albicans
Fungi Negative
Fungi Negative
Bacteria Negative
Fungi Negative
Mycoplasmal culture Negative
Mycoplasma test (PCR)b Negative
Endotoxin 0.136 EU/mL
Fungi Candida albicans
od shown by Jensen JS et al. [12].
Fig. 1. Candida albicans (C. albicans) proliferating in the cell culture supernatant of human oral mucosal epithelial cells in this clinical study. (A) Human oral mucosal tissue of the
patient. Bar ¼ approximately 1 cm. (B) Oral mucosal epithelial cells derived from the patient after cell preparation. Bar ¼ 100 mm. (C) Cellular morphology of the cultured human
oral mucosal epithelial cells. Bar ¼ 100 mm. (D) C. albicans observed on the cultured epithelial cells in a culture vessel. Bar ¼ 100 mm. (E) Histological observation of the C. albicans
adhering to a cultured epithelial cell sheet harvested from a temperature-responsive culture insert. The cell sheet and C. albicans were stained with hematoxylin and eosin.
Bar ¼ 50 mm.
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as cell sheets (Table 1, Fig. 2). To maintain a sterile environment, the
temperature-responsive cell culture inserts to which the cultured
epithelial cell sheets adhered were placed in transportable con-
tainers while in the safety cabinet of a clean room specialized for
fabricating transplantable cell sheets for a clinical setting. The
containers were then transported to Nagasaki University Hospital in
the transportation box, which was mounted on a hot plate to keep
the temperature at 37 C. After transport, the epithelial cell sheets
were ﬁnally transplanted onto the esophageal ulcer of the patient
after endoscopic dissection to remove esophageal cancer.
Here, we have reported our experience of contamination with
C. albicans during the fabrication of transplantable oral mucosalepithelial cell sheets derived from a patient who was not suffering
from candidiasis. By adding 1 mg/mL amphotericin B to the trans-
portation medium, fungal proliferation was completely inhibited
and esophageal mucosal regeneration was successfully observed.
Therefore, the method described in this report should be useful for
preventing contamination with C. albicans without increasing the
concentration of amphotericin B in the culture medium.
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